Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

STRATA Skin Science Announces Strengthening Of Leadership Team; Shmuel Gov Promoted To Chief Operating Officer

Author: Benzinga Newsdesk | December 04, 2023 09:10am

Shmuel Gov Promoted to Chief Operating Officer

 

Dr. Amandeep Kaur Hired as Vice President of Marketing and Business Growth

HORSHAM, Pa., Dec. 04, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced the promotion of Shmuel Gov to Chief Operating Officer. The Company has also hired Dr. Amandeep Kaur as Vice President of Marketing and Business Growth.

"I am pleased to announce the promotion of Shmuel to Chief Operating Officer. His outstanding leadership, strategic insight, and continued commitment to our mission make him the ideal choice to drive our operational excellence. This appointment reflects our confidence in Shmuel's ability to elevate our organization. I look forward to his continued impact and working more closely with him again as we revamp our direct-to-consumer activities, and services to our customers, allowing me to focus on the sales, marketing, business development and the aspects of managing the overall Company," commented Dr. Dolev Rafaeli, Vice Chairman and Chief Executive Officer.

Shmuel Gov brings over 30 years of industry experience in medical device business, operations, and R&D and, most recently, was STRATA's Senior Vice President and General Manager in charge of operations at the Company's manufacturing and R&D facility in Carlsbad, CA. Prior to joining the Company as Vice President and General Manager, he managed the acquisition of LasikPlus for Photomedex (from whom STRATA acquired its core XTRAC® and VTRAC® product lines), in which he was instrumental in building the unique go-to-market strategy of providing value-added services to the XTRAC partners. In 2015, he transitioned to STRATA after STRATA acquired XTRAC and has led the technological updates and the R&D of the XTRAC product line, including the launch of S3® and Momentum®. He has also created an in-house call center and enhanced the reimbursement support functions. Mr. Gov holds degrees in electronics engineering and international business management.

"I am truly honored to take on the pivotal role of Chief Operating Officer. This promotion not only acknowledges my individual contributions but also reflects the unwavering dedication of our exceptional team. I look forward to leading and contributing to STRATA's growth, promoting operational excellence, and tackling the challenges ahead. Together, we will reach new heights and achieve success in our shared journey," expressed Shmuel Gov, Chief Operating Officer of STRATA.

Additionally, Dr. Amandeep Kaur has rejoined STRATA and brings years of experience and background in business development, marketing, and technology. In her previous tenure at STRATA, Dr. Kaur was instrumental in business development efforts, led the XTRAC at-home initiative, managed multiple clinical studies and their publications, and worked closely with the clinical, marketing, and sales teams on multiple marketing and sales initiatives. Dr. Kaur earned her Master of Business Administration from Cornell University Johnson School of Business.

Dr. Rafaeli commented further, "It is a pleasure to have Dr. Kaur rejoin our team, and we look forward to her contributions as we revitalize our sales and marketing efforts to align with our new business objectives. Aman brings subject matter knowledge and a specific understanding of how the unique STRATA go-to-market approach of providing value-added services helps grow the recurring sales model. Her close ties with the clinical and research community and her experience as a business development leader will help STRATA accomplish its near-term turn-around goals."

Posted In: SSKN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist